Minority-Based Community Clinical Oncology Program Groups

by: Iola Bonggay

The National Institutes of Health, more commonly referred to as NIH, is a federal government agency operating under the purview of the United States Department of Health and Human Services that is primarily responsible for supporting the nation's biomedical and health-related research studies.

The grants and programs of the NIH are all magnanimously engineered to assist in the realization of its primary agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In line with this mission, the National Institutes of Health has recently collaborated with the National Cancer Institute (NCI) in an attempt to establish the Minority-Based Community Clinical Oncology Program Groups (MBCCOP).

The primary purpose of the program is to support research initiatives involving physicians who are participating in the care of minorities and who are eligible to participate in NCI-sponsored cancer prevention, control, and treatment clinical trials.

In addition, the program also serves as an opportunity for practicing oncologists who serve large racial/ethnic minority populations to participate in clinical trials sponsored by the National Cancer Institute.

Essentially, this program is designed to cater to minority populations and to bring forth state-of-the-art cancer clinical trials to minority individuals in their own communities.

  (continued...)

Minority-Based Community Clinical Oncology Program Groups
  Page 2

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Identifying Heart, Lung, and Blood Disease-Causing Variants
The National Institutes of Health has formed a partnership with the National Heart, Lung, and Blood Institute to establish a program that aims to Identify Heart, Lung, and Blood Disease-Causing Variants.

---

Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award Program
The National Institutes of Health has recently form a partnership with the National Cancer Institute in an effort to establish the Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award Program.

---

Health Resources and Services Administration's Licensure Portability Grant Program
The Health Resources and Services Administration has constituted the Licensure Portability Grant Program (LPGP) wherein they aim to improve the experience of State licensing boards that have manifested a credible record in implementing cross-border activities in order to help overcome licensure barriers in the provision of telemedicine services across various States.

---